Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt

Diarrhea: early-phase trial registry

7 of 25 indexed Diarrhea trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #652 of 28,707 conditions by registered trial count.

25 US clinical trials · 7 currently recruiting · #652 of 28,707 conditions by registered trial count

Diarrhea: 25 US clinical trials tracked, 7 recruiting.

Diarrhea is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Bausch Health Americas, running 2 of these trials.

Enrollment posture brief

Registry condition diarrhea

OPEN 7 | RECR 28% | LATE 3 | EARLY 15 | RANK #652 | SPON 2

Nearest open-share peer: Pain (28% recruiting · 377 trials)

Alpha-1 Antitrypsin Deficien48%Alcohol Use40%Acute Lymphocytic Leukemia36%Alcohol-Related Disorders36%Diarrhea (this)28%
Open-enrollment share among volume-matched conditions near Diarrhea

Diarrhea lists 7 open slots (28% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diarrhea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diarrhea is recruiting below its size-band peers.

    7 of 25 indexed trials (28%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Diarrhea trials is spread across many organizations.

    Bausch Health Americas accounts for 2 of 25 trials (8%). 23 distinct sponsors appear on at least one study for this condition label.

  3. Most Diarrhea trials plan to enrol fewer than 100 people.

    Median target enrolment is 54 among the 25 trials that report a genuine target (sentinel values excluded). 17 of those (68%) plan for fewer than 100 participants.

  4. Diarrhea research is mostly interventional.

    23 interventional and 2 observational studies make up this index (92% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 17Phase 28Phase 31Phase 42

Open and recent trials

25 total, page 1 of 1

RECRUITING Phase 1 60 participants

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

Inventprise

NCT07205926

RECRUITING Phase 4 54 participants

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

Bausch Health Americas

NCT07285785

RECRUITING Phase 2 43 participants

Fecal Microbiota Transplantation for IBS

Madhusudan (Madhu) Grover, MBBS

NCT05776914

RECRUITING Phase 1 40 participants

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

NCT04038619

RECRUITING NA 30 participants

GI Alpha-Gal Study

University of North Carolina, Chapel Hill

NCT06268717

RECRUITING Early Phase 1 20 participants

Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator

Mayo Clinic

NCT06684470

RECRUITING Phase 1 15 participants

A Study of SER-155 to Treat Diarrhea in People on Immunotherapy

Memorial Sloan Kettering Cancer Center

NCT06801067

ACTIVE NOT RECRUITING NA 908 participants

Wells and Enteric Disease Transmission

Temple University

NCT04826991

ACTIVE NOT RECRUITING Phase 2 60 participants

Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

Gut-Brain-Axis Therapeutics

NCT06503978

ACTIVE NOT RECRUITING Phase 2 50 participants

MTT for Children With ASD Who Have Gastrointestinal Disorders

Arizona State University

NCT04182633

COMPLETED NA 810 participants

A Trial of Tap Water Treatment in the Elderly

National Institute on Aging (NIA)

NCT00058942

COMPLETED 308 participants

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

NCT00048971

COMPLETED NA 255 participants

Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform

Cedars-Sinai Medical Center

NCT02436057

COMPLETED Phase 2 245 participants

A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome

Bausch Health Americas

NCT00101725

COMPLETED Phase 2 210 participants

Study of CB-183,315 in Participants With Clostridium Difficile Infection

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

NCT01085591

COMPLETED Phase 2 201 participants

ETEC Logistics Trial (TREK)

Intercell USA

NCT00516659

COMPLETED Phase 3 190 participants

Yogurt Study in Children 2-4 Years Old Attending Daycare

Georgetown University

NCT00760851

COMPLETED Phase 2 60 participants

Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model

Immuron

NCT05933525

COMPLETED Phase 1 58 participants

Dose Escalating Study of Intramuscular Invaplex[AR-DETOX]

PATH

NCT03869333

COMPLETED Phase 4 41 participants

Examining the Effect of Ondansetron on Bowel Prep Success

State University of New York - Downstate Medical Center

NCT05439772

COMPLETED Phase 1 32 participants

Invaplex 50 Vaccine Dose-Ranging

U.S. Army Medical Research and Development Command

NCT00082069

COMPLETED 30 participants

AcuGraph and Digestive Symptoms

Logan College of Chiropractic

NCT00846794

COMPLETED Phase 2 25 participants

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Memorial Sloan Kettering Cancer Center

NCT03767257

COMPLETED NA 21 participants

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

City of Hope Medical Center

NCT02944617

COMPLETED Phase 1 2 participants

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Roswell Park Cancer Institute

NCT00084721

Phase Distribution

PhaseTrial count
Phase 1 7
Phase 2 8
Phase 3 1
Phase 4 2

Named interventions

Most-linked intervention names on Diarrhea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Other
3 trials
CB-183,315 Drug
1 trials
Shigella flexneri 2a Invaplex 50 Biological
1 trials
Heat-Labile Enterotoxin of Escherichia coli (LT) Biological
1 trials
Invaplex[AR-DETOX] Biological
1 trials
Travelan Biological
1 trials
crofelemer Drug
1 trials
AEGIS (Automated Evaluation of Gastrointestinal Symptoms) Other
1 trials

US sites by state

Facility locations filed on Diarrhea trials. A trial with sites in several states counts in each.

New York 7 trials
California 6 trials
Maryland 5 trials
Florida 5 trials
Illinois 4 trials
Texas 3 trials
Ohio 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diarrhea page

25 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diarrhea condition card totals 25 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.